This Revolutionary, Highly Accurate At-Home Test Will Tell You…
Quick question: How do you test your personal gut health?
Technology in the microbiome world is moving quickly, and we have added a new recommendation that’s really state of the art.
To illustrate, let’s suppose you have digestive issues. Maybe you have Crohn’s, ulcerative colitis, IBS, or just discomfort like diarrhea or constipation. If you have a bug (like bacteria, fungus, or yeast), this can make it difficult to overcome your symptoms. You can spend months or even years in discomfort, until you eliminate the bad effect of the bugs.
How do you know what’s going on in your gut? What’s the root cause of your digestive discomfort?
Doctor’s Data Test will help you find out..
Doctor’s Data uses a test called the MALDI TOF, which has revolutionized clinical microbiology. The MALDI TOF test gives you a comprehensive–and easy to interpret–evaluation of your gastrointestinal (GI) bacteria and yeast.
In other words, if you have a bug that’s been causing your discomfort, you will know about it. And you’ll be able to solve it to finally relieve your symptoms.
One key feature to MALDI-tof is home stool testing. Unlike many other tests, with MALDI-tof, you can test at home. But the convenience isn’t the main reason I now recommend Doctor’s Data’s improved test to my patients.
The real reason is that this MALDI-tof test is very revealing.
You see, some bugs have been shown to have either positive or negative impact directly in your gut, and even systemically (throughout your entire body).
Hospitals and national chain laboratories report only pathogenic bacteria and rarely, if ever, GI yeast.
However, a plethora of published research to date provides a strong case for the need to evaluate the microbiome in a much more comprehensive and interpretable manner. You want to know if you have yeast growth in your GI tract.
Your gut has its own environment of organisms. If you don’t check for bad bugs, then you could suffer needlessly.
The best way to test your personal microbiome right now is to use “genomic technologies” like the MALDI-tof test.
This test is considered superior to culture, because some microbes cannot currently be cultured.
The MALDI tof test, on the other hand, is an accurate, reliable test that identifies bacteria and yeast in your gut – and may be more helpful than commercial culture tests.
Here’s why …… many attempts have been made to try to define a healthy “normal” GI microbiome but the composition and function of an optimal healthy microbiome is yet to be clearly defined. There has been recent criticism of the media hype regarding microbiomics and skepticism about commercial metagenomic analysis and interpretation of results for personal fecal samples. Genomic technologies are considered superior to culture because they can identify microbes that are not typically cultured, or cannot currently be cultured (like yeast)
MALDI-TOF MS is an accurate, reliable technology that identifies bacteria and yeast in your gut.
Using the largest open and ever expanding reference database, the proteomic method has markedly increased identification of GI microbiota and thereby provides the most clinically relevant, comprehensive, and interpretable evaluation of a patient’s microbiome.
I highly recommend my patients take the MALDI TOF test by Doctor’s Data. To encourage you to check for discomfort-causing yeast and bacteria in your body, if you take the MALDI TOF test. and to learn more and discover if you have bad bugs causing your discomfort, just go here:
If you have any questions, feel free to comment below, or email me at firstname.lastname@example.org.
References and Further Reading
The Culture-Based Revolution in Gastrointestinal Microbiology: A Proteomic Method for Microbial Identification
By David Quig, PhD, VP Scientific Support, Doctor’s Data, Inc.
Khanna S, Tosh PK. Mayo Clinic Proceedings. 2014;89:107-14.
Betts KS. Environ Hlth Perspect. 2011;119:a340-6.
Backhed F, et al. Cell Host Microbe. 2012;12:611-22.
Hanage WP. Nature. 2014;512:247-8.
Dave M, et al. Transl Res. 2012;160:246-7.
Dubourg G, et al. Eur J Clin Microbiol Infect Dis. 2013;32:1099.
Hugon P, et al. J Clin Microbiol. 2013;51:3286-93.
Lagier J-C, et al. Frontiers in Cellular and Infection Microbiol. 2012;2:1-19.
Pfl eiderer A, et al. Eur J Clin Microbiol Infect Dis.2013;32:1471-81.
Mellmann A, et al. J Clinl Microbiol. 2009;47:3732-4.
Stevenson LG, et al. J Clin Microbiol. 2010;48:3482-6.
Titus K. CAP Today. 2013;27(1). Available at www.CAP.org.